Drugs for Neglected Diseases initiative 10d ago

💊 Today, hope is growing for people like Mbo. The Democratic Republic of the Congo (DRC) has approved acoziborole, a single-dose oral treatment for sleeping sickness! Mbo is a living testament to this scientific progress. She lost her husband to sleeping sickness but was cured when she received acoziborole as part of clinical trials run by the Drugs for Neglected Diseases initiative (DNDi) in the DRC and Guinea. Today, she shares a powerful message: trust the research, trust the treatment, and seek care early. ⚕️ The World Health Organization (WHO) is updating treatment guidelines for countries, supporting access to treatments across all Central and West African endemic countries, and coordinating efforts to eliminate sleeping sickness by 2030. Thank you, Mbo, for your message and proof that scientific innovation can save lives and rebuild trust in communities. #1Dose1Cure #NeglectedDiseases #BeatNTDs #SleepingSickness #StandWithScience ---------------------- The Drugs for Neglected Diseases initiative (DNDi) is an international non-profit developing safe, effective, and affordable treatments for the most neglected patients. https://dndi.org